Global Nanomedicine Development and Manufacturing Services Market Growth (Status and Outlook) 2025-2031

The global Nanomedicine Development and Manufacturing Services market size is predicted to grow from US$ 111 million in 2025 to US$ 151 million in 2031; it is expected to grow at a CAGR of 5.3% from 2025 to 2031.

Nanomedicine development and manufacturing services refer to specialized offerings provided by biotechnology and pharmaceutical companies, research institutions, or dedicated contract service providers. These services involve the comprehensive utilization of nanotechnology to design, develop, and produce nanoscale-based medical products, including but not limited to nanocarriers for drug delivery, nanoparticle-based imaging agents, and nanomaterials for therapeutic applications. The process encompasses aspects like precise nanoparticle synthesis, functionalization for specific biological targeting and performance optimization, along with strict adherence to regulatory requirements for safety and efficacy, all aimed at improving healthcare outcomes through innovative nanomedicine solutions.

United States market for Nanomedicine Development and Manufacturing Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Nanomedicine Development and Manufacturing Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Nanomedicine Development and Manufacturing Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Nanomedicine Development and Manufacturing Services players cover Ardena, nanoComposix （Fortis Life Sciences ）, Cytiva, Sino Biological, Taichu Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Nanomedicine Development and Manufacturing Services Industry Forecast” looks at past sales and reviews total world Nanomedicine Development and Manufacturing Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Nanomedicine Development and Manufacturing Services sales for 2025 through 2031. With Nanomedicine Development and Manufacturing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nanomedicine Development and Manufacturing Services industry.

This Insight Report provides a comprehensive analysis of the global Nanomedicine Development and Manufacturing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nanomedicine Development and Manufacturing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nanomedicine Development and Manufacturing Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nanomedicine Development and Manufacturing Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nanomedicine Development and Manufacturing Services.

This report presents a comprehensive overview, market shares, and growth opportunities of Nanomedicine Development and Manufacturing Services market by product type, application, key players and key regions and countries.

Segmentation by Type:
Development Services
Manufacturing Services

Segmentation by Application:
Treatment
Diagnosis
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Ardena
nanoComposix （Fortis Life Sciences ）
Cytiva
Sino Biological
Taichu Group
Fraunhofer IMM
xfnano
Nuohai Life Science（Shanghai）Co.,Ltd

Please note: The report will take approximately 2 business days to prepare and deliver. Show more